Tenet Healthcare Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Tenet Healthcare Corporation
- Former names
- National Medical Enterprises Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 8062 — Services-General Medical & Surgical Hospitals, NEC
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Dallas
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- THC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000070318
- EIN
- 95-2557091
Board of directors
-
Cecil D. Haney · DirectorSince 2023
-
Christopher S. Lynch · DirectorSince 2023
-
J. Robert Kerrey · DirectorSince 2023
-
James L. Bierman · DirectorSince 2023
-
Meghan Fitzgerald · DirectorSince 2023
-
Nadja West · DirectorSince 2023
-
Richard J. Mark · DirectorSince 2023
-
Richard W. Fisher · DirectorSince 2023
-
Roy Blunt · DirectorSince 2023
-
Saumya Sutaria · Director · CEOSince 2023
-
Stephen H. Rusckowski · DirectorSince 2023
-
Tammy Romo · DirectorSince 2023
-
Vineeta Agarwala · DirectorSince 2023
Chief executives
Saumya Sutaria
· CEO
Dates unknown
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.2%
-
99.2%
Board connections
11 of this board's directors also sit on 16 other boards.
- via Stephen H. Rusckowski
- via Richard W. Fisher
- via Vineeta Agarwala
- via Christopher S. Lynch
- via Richard J. Mark
- via Cecil D. Haney
- via Nadja West
- via James L. Bierman
- via Nadja West
- via Stephen H. Rusckowski
- via Stephen H. Rusckowski
- via Meghan Fitzgerald
- via Tammy Romo
- via Roy Blunt
- via Nadja West
- via Richard W. Fisher
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $71,697,282
- 43 sales by 14 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | J. Robert Kerrey Director | Open-market sale | −5,483 | $263.04 | $1,442,248 |
| Sep 14, 2026 | J. Robert Kerrey Director | Open-market sale | −4,025 | $264.10 | $1,063,003 |
| Sep 14, 2026 | J. Robert Kerrey Director | Open-market sale | −2,502 | $264.62 | $662,079 |
| Sep 10, 2026 | Richard J. Mark Director | Open-market sale | −10,000 | $263.42 | $2,634,200 |
| Sep 2, 2026 | Nadja West Director | Open-market sale | −1,152 | $258.80 | $298,138 |
| Aug 31, 2026 | Foo Lisa Y Officer (EVP, Chief Operating Officer) | Open-market sale | −24,000 | $266.32 | $6,391,680 |
| Aug 28, 2026 | Cecil D. Haney Director | Gift | −150 | — | — |
| Aug 25, 2026 | Saumya Sutaria Director, Officer (CEO) | Open-market sale | −17,220 | $273.34 | $4,706,915 |
| Aug 25, 2026 | Saumya Sutaria Director, Officer (CEO) | Open-market sale | −24,881 | $274.10 | $6,819,882 |
| Aug 25, 2026 | Saumya Sutaria Director, Officer (CEO) | Open-market sale | −7,899 | $275.26 | $2,174,279 |
| Aug 24, 2026 | Cecil D. Haney Director | Open-market sale | −1,300 | $278.03 | $361,439 |
| Aug 24, 2026 | Saumya Sutaria Director, Officer (CEO) | Open-market sale | −13,344 | $278.17 | $3,711,900 |
| Aug 24, 2026 | Saumya Sutaria Director, Officer (CEO) | Open-market sale | −36,656 | $278.90 | $10,223,358 |
| Aug 7, 2026 | Tammy Romo Director | Open-market sale | −2,500 | $260.83 | $652,075 |
| Aug 6, 2026 | Tammy Romo Director | Open-market sale | −4,922 | $264.15 | $1,300,146 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.